Multicenter Phase I Clinical Trial of Daily and Weekly RAD001 (everolimus) in Combination with Vinorelbine and Trastuzumab in Patients with HER-2-overexpressing Metastatic Breast Cancer with Prior Resistance to Trastuzumab.
Cancer Research（2009）
Key words
Cancer
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined